 |
|
Unreported Financial Disclosures in: Women's Susceptibility to Tobacco Carcinogens and Survival After Diagnosis of Lung Cancer
JAMA. 2008;299(15):1775.
Unreported Financial Disclosures: In the Original Contribution entitled "Women's Susceptibility to Tobacco Carcinogens and Survival After Diagnosis of Lung Cancer" published in the July 12, 2006, issue of JAMA (2006;296[2]:180-184) and in the Letter entitled "Computed Tomography Screening for Lung Cancer" published in the August 1, 2007, issue of JAMA (2007;298[5]:514-515), financial disclosures were not reported. See also related Correction, Letter, and Reply in this issue. The paragraph should have read as follows:
Financial Disclosures: Drs Henschke and Yankelevitz reported being listed as co-inventors for the following patent and patent applications: US Patent No. 7,274,810, "System and Method for Three-Dimensional Image Rendering and Analysis" (patent issued to CRF September 25, 2007); US Patent Application No. 10/245,782, "System, Method and Apparatus for Small Pulmonary Nodule Computer Aided Diagnosis from Computed Tomography Scans" (CRF pending patent application); US Patent Application No. 11/827,985, "System and Method for Three-Dimensional Image Rendering and Analysis" (CRF pending divisional application); US Patent Application No. 11/827,994, "System and Method for Three-Dimensional Image Rendering and Analysis" (CRF pending divisional application); US Patent Application No.10/688,267, "System, Method and Apparatus for Small Pulmonary Nodule Computer Aided Diagnosis from Computed Tomography Scans" (CRF pending patent application); US Patent Application No. 10/901,316, "System and Method for Providing Remote Analysis of Medical Data" (CRF pending patent application); US Patent Application No.10/932,443, "System and Method for Analyzing Medical Data to Determine Diagnosis and Treatment" (CRF pending patent application); US Patent Application No. 10/901,362, "System and Method for Conducting a Clinical Trial Study" (CRF pending patent application); US Patent Application No. 11/688,980, "Medical Imaging Visibility Index System and Method for Cancer Lesions" (CRF patent cooperation treaty application also pending); US Patent Application No. 11/377,031, "Method for Expanding the Domain of Imaging Software in a Diagnostic Workup" (CRF pending patent application) (foreign patent applications also pending); US Patent Application No. 11/858,855, "System and Method for Position Matching of a Patient for Medical Imaging" (CRF pending patent application); and "Medical Imaging System for Accurate Measurement Evaluation of Changes in a Target Lesion" (foreign patent applications pending) (Henschke/Yankelevitz pending patent application). Dr Henschke reported receiving compensation for serving as a member of a National Cancer Institute study section. Dr Yankelevitz reported being an inventor on a pending patent related to biopsy needles assigned to PneumRX, being a paid medical advisor to PneumRX, and holding stock in PneumRX.
Research Support: The institutions that comprise I-ELCAP have received research support over the last 10 years from National Institutes of Health grants R01-CA-63393l and R01-CA-78905; Department of Energy grant DE-FG02-96SF21260; Department of Defense grant; The City of New York, Department of Health and Mental Hygiene; New York State Office of Science, Technology and Academic Research (NYSTAR); American Cancer Society; Israel Cancer Association; The Starr Foundation; The New York Community Trust; The Rogers Family Fund; The Foundation for Lung Cancer: Early Detection, Prevention, and Treatment (with funding from the Vector Group, the parent company of Liggett Tobacco); Foundation for Early Detection of Lung Cancer; Dorothy R. Cohen Foundation, Research Foundation of Clinic Hirslanden; Yad-Hanadiv Foundation; Jacob and Malka Goldfarb Charitable Foundation; Auen/Berger Foundation; Princess Margaret Foundation; Berger Foundation; Tenet Healthcare Foundation; Ernest E. Stempel Foundation, Academic Medical Development Corporation; Empire Blue Cross and Blue Shield; Weill Medical College of Cornell University; Cornell University; New York Presbyterian Hospital; Clinic Hirslanden; Swedish Hospital; Christiana Care Helen F. Graham Cancer Center; Holy Cross Hospital; Eisenhower Hospital; Jackson Memorial Hospital Health System; and Evanston Northwestern Healthcare.
Published Online: March 24, 2008 (doi:10.1001/jama.299.15.jcx80007).
RELATED ARTICLE
Unreported Financial Disclosures in: Women's Susceptibility to Tobacco Carcinogens and Survival After Diagnosis of Lung Cancer
JAMA. 2008;299(15):1775.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Unreported Financial Disclosures--Reply
DeAngelis
JAMA 2008;299:1771-1771.
FULL TEXT
|
